首页 | 官方网站   微博 | 高级检索  
     

68Ga-DOTA-生长抑素受体PET/CT神经内分泌肿瘤显像操作指南
引用本文:陈跃,霍力,兰晓莉,张蜀茂,刘建军,徐浩,李囡,李亚明,李思进. 68Ga-DOTA-生长抑素受体PET/CT神经内分泌肿瘤显像操作指南[J]. 中国医学影像技术, 2019, 35(9): 1281-1284
作者姓名:陈跃  霍力  兰晓莉  张蜀茂  刘建军  徐浩  李囡  李亚明  李思进
作者单位:西南医科大学附属医院核医学科 核医学与分子影像四川省重点实验室, 四川 泸州 646000,中国医学科学院北京协和医学院北京协和医院核医学科, 北京 100730,华中科技大学同济医学院附属协和医院核医学科 湖北省分子影像重点实验室, 湖北 武汉 430022,西南医科大学附属医院核医学科 核医学与分子影像四川省重点实验室, 四川 泸州 646000,上海交通大学医学院附属仁济医院核医学科, 上海 200127,暨南大学附属第一医院核医学科, 广东 广州 510630,北京大学肿瘤医院暨北京市肿瘤防治研究所核医学科 恶性肿瘤发病机制及转化研究教育部重点实验室, 北京 100142,中国医科大学附属第一医院核医学科, 辽宁 沈阳 110001,山西医科大学第一医院核医学科, 山西 太原 030001
基金项目:核医学与分子影像四川省重点实验室核医学创新转化平台(19PTDJ0009)。
摘    要:本指南针对神经内分泌肿瘤患者提出68Ga-DOTA-生长抑素受体PET/CT检查的临床适应证、核医学医务人员岗位要求、检查操作规范、报告处理、质量控制及显像过程中的辐射安全问题,为临床进行68Ga-DOTA-生长抑素受体PET/CT检查提供相应操作规范,为各种影像学表现提供合理解释和标准的诊断报告。

关 键 词:神经内分泌瘤  受体,生长抑素  正电子发射断层显像术  体层摄影术,X线计算机  指南
收稿时间:2019-05-08
修稿时间:2019-06-28

Guideline of 68Ga-DOTA-conjugated somatostatin receptor PET/CT imaging in neuroendocrine neoplasms
CHEN Yue,HUO Li,LAN Xiaoli,ZHANG Shumao,LIU Jianjun,XU Hao,LI Nan,LI Yaming and LI Sijin. Guideline of 68Ga-DOTA-conjugated somatostatin receptor PET/CT imaging in neuroendocrine neoplasms[J]. Chinese Journal of Medical Imaging Technology, 2019, 35(9): 1281-1284
Authors:CHEN Yue  HUO Li  LAN Xiaoli  ZHANG Shumao  LIU Jianjun  XU Hao  LI Nan  LI Yaming  LI Sijin
Affiliation:Department of Nuclear Medicine, the Affiliated Hospital of Southwest Medical University, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, China,Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China,Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, China,Department of Nuclear Medicine, the Affiliated Hospital of Southwest Medical University, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, China,Department of Nuclear Medicine, Renji Hospital, Medical College of Shanghai Jiaotong University, Shanghai 200127, China,Department of Nuclear Medicine, the First Affiliated Hospital of Jinan University, Guangzhou 510630, China,Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing 100142, China,Department of Nuclear Medicine, the First Hospital of China Medical University, Shenyang 110001, China and Department of Nuclear Medicine, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
Abstract:This guideline was aimed to provide clinical indications, responsibilities of nuclear medicine personnel, procedures of examination, imaging intervention, quality control and radiation safety on PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor. The purpose of this guideline was to provide standards for examination of PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor, reasonable explanation and diagnostic report for various imaging manifestations.
Keywords:neuroendocrine tumors  receptors, somatostatin  positron-emission tomography  tomography, X-ray computed  guideline
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号